Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-026140
Filing Date
2021-11-10
Accepted
2021-11-10 16:03:56
Documents
50
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20210930_10q.htm   iXBRL 10-Q 911604
2 EXHIBIT 31.1 ex_286378.htm EX-31.1 15825
3 EXHIBIT 31.2 ex_286379.htm EX-31.2 15401
4 EXHIBIT 32.1 ex_286380.htm EX-32.1 8607
  Complete submission text file 0001437749-21-026140.txt   4359808

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20210930.xsd EX-101.SCH 43846
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20210930_cal.xml EX-101.CAL 30062
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20210930_def.xml EX-101.DEF 313581
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20210930_lab.xml EX-101.LAB 275072
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20210930_pre.xml EX-101.PRE 325208
10 EXTRACTED XBRL INSTANCE DOCUMENT wint20210930_10q_htm.xml XML 552664
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 211396469
SIC: 2836 Biological Products, (No Diagnostic Substances)